Literature DB >> 6311344

Regulation of indoleamine N-acetyltransferase activity in the retina: effects of light and dark, protein synthesis inhibitors and cyclic nucleotide analogs.

P M Iuvone, J C Besharse.   

Abstract

The regulation of indoleamine N-acetyltransferase (NAT) in the posterior eye was investigated in vivo, and in vitro in cultured eye cups. Surgical separation of neural retina from the retinal pigment epithelium-choroid complex indicated that NAT was localized to neural retina. The activity of retinal NAT fluctuated in vivo in a rhythmic fashion, with peak activity in the dark phase of the light-dark cycle. The rhythm of NAT activity persisted for up to 3 days in constant darkness, with a rhythmic period of approximately 25 h. The rhythm was suppressed by constant light, and could be phase-shifted by exposure to a new light-dark cycle. These observations indicate that retinal NAT activity occurs as a circadian rhythm that is entrained by light and dark. Retinas also responded to light and dark in vitro with changes of NAT activity. A significant increase in retinal NAT activity occurred in eye cups cultured in darkness during the dark phase of the light-dark cycle. This increase was completely suppressed in eye cups cultured at the same time of day in light. The dark-induced increase in NAT was completely blocked by protein synthesis inhibitors, and mimicked in light by cyclic AMP analogs. The similarity of the regulation of NAT activity in retina to that in pineal, and the possible relationship of the retinal NAT rhythm to cyclic metabolism in photoreceptors are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311344     DOI: 10.1016/0006-8993(83)91099-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Diurnal variations in the electroretinographic c-wave and retinal melatonin content in rats with inherited retinal dystrophy.

Authors:  M Hawlina; H G Jenkins; H Ikeda
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Circadian rhythm of tryptophan hydroxylase activity in chicken retina.

Authors:  K B Thomas; P M Iuvone
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

3.  Ontogenetic development of S-antigen- and rod-opsin immunoreactions in retinal and pineal photoreceptors of Xenopus laevis in relation to the onset of melatonin-dependent color-change mechanisms.

Authors:  B Korf; M D Rollag; H W Korf
Journal:  Cell Tissue Res       Date:  1989-11       Impact factor: 5.249

Review 4.  Circadian regulation in the retina: From molecules to network.

Authors:  Gladys Y-P Ko
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 5.  The Retina and Other Light-sensitive Ocular Clocks.

Authors:  Joseph C Besharse; Douglas G McMahon
Journal:  J Biol Rhythms       Date:  2016-04-19       Impact factor: 3.182

6.  Paracrine control of photomembrane removal.

Authors:  N A Dahl
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

7.  Retinal melatonin is metabolized within the eye of xenopus laevis.

Authors:  G M Cahill; J C Besharse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 8.  Rhythmic regulation of retinal melatonin: metabolic pathways, neurochemical mechanisms, and the ocular circadian clock.

Authors:  G M Cahill; M S Grace; J C Besharse
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

9.  The Calcineurin-Binding, Activity-Dependent Splice Variant Dynamin1xb Is Highly Enriched in Synapses in Various Regions of the Central Nervous System.

Authors:  Marie-Lisa Eich; Ekta Dembla; Silke Wahl; Mayur Dembla; Karin Schwarz; Frank Schmitz
Journal:  Front Mol Neurosci       Date:  2017-07-25       Impact factor: 5.639

Review 10.  Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases.

Authors:  Yuyi Han; Qianwen Shang; Jin Yao; Yong Ji
Journal:  Cell Death Dis       Date:  2019-03-29       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.